Organization and Description of Business - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands |
9 Months Ended | |||
---|---|---|---|---|
Sep. 18, 2020 |
Aug. 31, 2020 |
Sep. 30, 2020 |
Dec. 31, 2019 |
|
Subsidiary, Sale of Stock [Line Items] | ||||
Stock issued during period options exercised | 1,115,535 | |||
Proceeds from Issuance Initial Public Offering | $ 395,211 | |||
Conversion of Stock, Shares Converted | 52,063,647 | |||
Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | 138,400 | |||
Deferred Offering Costs | $ 5,400 | $ 500 | ||
IPO [Member] | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Stock issued during period | 9,735,232 | |||
Stock issued during period options exercised | 1,735,232 | |||
Sale of Stock, Price Per Share | $ 44.00 | |||
Proceeds from Issuance Initial Public Offering | $ 393,200 | |||
Underwriting discounts and commissions | 30,000 | |||
Other issuance costs | $ 5,100 |
X | ||||||||||
- Definition Other issuance costs No definition available.
|
X | ||||||||||
- Definition Underwriting discounts and commissions No definition available.
|
X | ||||||||||
- Definition The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The cash inflow associated with the amount received from entity's first offering of stock to the public. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. No definition available.
|
X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Details
|